Skip to main content

Advertisement

Log in

Ropinirole versus placebo in primary restless legs syndrome

  • Clinical Trials Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jankovic J, Beach J: Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358–362.

    PubMed  CAS  Google Scholar 

  2. Ondo WG, Tintner R, Thomas M, Jankovic J: Tetrabenazine treatment for Huntington’s disease-associated chorea. Clin Neuropharmacol 2002, 25:300–302.

    Article  PubMed  CAS  Google Scholar 

  3. McLellan DL, Chalmers RJ, Johnson RH: A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea. Lancet 1974, 1:104–107.

    Article  PubMed  CAS  Google Scholar 

  4. Jankovic J: Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982, 11:41–47.

    Article  PubMed  CAS  Google Scholar 

  5. Allen RP, Picchietti D, Hening WA, et al.: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101–119.

    Article  PubMed  Google Scholar 

  6. Phillips B, Hening W, Britz P, Mannino D: Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest 2006, 129:76–80.

    Article  PubMed  Google Scholar 

  7. Earley CJ, Allen RP: Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996, 19:801–810.

    PubMed  CAS  Google Scholar 

  8. Bogan RK, Fry JM, Schmidt MH, et al. ; TREATRLS US Study Group: Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 2006, 81:17–27.

    Article  PubMed  CAS  Google Scholar 

  9. Akpinar S: Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982, 39:739.

    PubMed  CAS  Google Scholar 

  10. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B: Restless legs syndrome improved by pramipexole. A double-blind randomized trial. Neurology 1999, 52:938–943.

    PubMed  CAS  Google Scholar 

  11. Walters AS, Ondo WG, Dreykluft R, et al. ; TREATRLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group: Ropinirole is effective in the treatment of restless legs syndrome TREAT RLS 2: a 12-week, doubleblind, randomized, parallel-group, placebo-controlled study. Mov Disord 2004, 19:1414–1423.

    Article  PubMed  Google Scholar 

  12. Ondo W, Romanyshyn J, Vuong KD, Lai D: Long-term treatment of restless legs syndrome with dopamine agonists. Arch Neurol 2004, 61:1393–1397.

    Article  PubMed  Google Scholar 

  13. Moller JC, Korner Y, Cassel W, et al.: Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome. Sleep Med 2006, In press.

  14. Dodd ML, Klos KJ, Bower JH, et al.: Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005, 62:1377–1381.

    Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morgan, J.C., Sethi, K.D. Ropinirole versus placebo in primary restless legs syndrome. Curr Neurol Neurosci Rep 6, 278–280 (2006). https://doi.org/10.1007/s11910-006-0018-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-006-0018-7

Keywords

Navigation